Richard James

Title: Richard James: Innovator in Cell-Based Immunotherapy

Introduction

Richard James is a notable inventor based in Seattle, WA. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on engraftable cell-based therapies. His research focuses on the long-term delivery of therapeutic proteins, which has the potential to transform treatment methodologies in medicine.

Latest Patents

Richard James holds a patent for "Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins." This patent relates to plasma cells and plasma cell precursors that express macromolecules, such as proteins, protein mimetics, or peptides. The application outlines methods for using and creating these plasma cells and their precursors, as well as treatment methods involving their administration.

Career Highlights

Richard is affiliated with Seattle Children's Hospital, where he continues to advance his research in immunotherapy. His work is pivotal in developing new therapeutic strategies that could improve patient outcomes in various medical conditions.

Collaborations

Richard collaborates with esteemed colleagues, including David J Rawlings and Shaun W Jackson. Their combined expertise enhances the research and development of innovative therapies in the field.

Conclusion

Richard James is a pioneering inventor whose work in cell-based immunotherapy is paving the way for new treatment options. His contributions are vital to the ongoing advancements in medical science and patient care.